P11.34 Bone Morphogenetic Protein 4 can sensitize glioblastoma cells to temozolomide

BACKGROUND: Glioblastoma (GBM) is the most prevalent and lethal primary brain tumor. Its recurrence and resistance to current therapies, i.e. temozolomide (TMZ), is thought to result from a subpopulation of cells exhibiting stem cell properties, called glioblastoma stem-like cells (GSCs). Bone Morph...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Verploegh, I, Conidi, A, Lamfers, M, Dirven, C, Leenstra, S, Huylebroeck, D
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Poster Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796144/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.180
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars